Finally, Kaplan–Meier survival analysis using the KMPlotter online tool indicated that low expression of SLC16A4 was associated with poorer overall survival in lung cancer patients, highlighting its potential as a prognostic biomarker (Figure 6H). Here, SLC16A4 is linked to lung cancer.